These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 31279904)

  • 21. Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.
    Gignac T; Trépanier G; Paquet V; Ferland S; Carreau AM
    Can J Diabetes; 2023 Oct; 47(7):603-610. PubMed ID: 37352972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults.
    Zhang J; Xu Q; Lai F; Chen N; Lin M; Liu Y; Zhang W; Liu C; Wang S; Li Z
    BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34433546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance.
    Fiorentino TV; Succurro E; Sciacqua A; Andreozzi F; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3333. PubMed ID: 32356922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening obese children and adolescents for prediabetes and/or type 2 diabetes in pediatric practices: a validation study.
    Brar PC; Mengwall L; Franklin BH; Fierman AH
    Clin Pediatr (Phila); 2014 Jul; 53(8):771-6. PubMed ID: 24671874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence of carbohydrate metabolism disturbances in a population of children and adolescents with severe obesity].
    Guijarro De Armas MG; Monereo Megias S; Civantos Modino S; Montaño Martínez JM; Iglesias Bolaños P; Durán Martínez M
    Endocrinol Nutr; 2010 Dec; 57(10):467-71. PubMed ID: 21051299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
    Xanthakos SA; Jenkins TM; Kleiner DE; Boyce TW; Mourya R; Karns R; Brandt ML; Harmon CM; Helmrath MA; Michalsky MP; Courcoulas AP; Zeller MH; Inge TH;
    Gastroenterology; 2015 Sep; 149(3):623-34.e8. PubMed ID: 26026390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of mismatches in HbA
    Gonzalez A; Deng Y; Lane AN; Benkeser D; Cui X; Staimez LR; Ford CN; Khan FN; Markley Webster SC; Leong A; Wilson PWF; Phillips LS; Rhee MK
    Diabet Med; 2020 Apr; 37(4):689-696. PubMed ID: 31721287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
    Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
    J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediabetes in patients treated with antipsychotic drugs.
    Manu P; Correll CU; van Winkel R; Wampers M; De Hert M
    J Clin Psychiatry; 2012 Apr; 73(4):460-6. PubMed ID: 22225552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects.
    Newfield RS; Graves CL; Newbury RO; Schwimmer JB; Proudfoot JA; Say DS; Feldstein AE
    Pediatr Diabetes; 2019 Feb; 20(1):41-47. PubMed ID: 30467936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes.
    Succurro E; Marini MA; Fiorentino TV; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    Diabetes Res Clin Pract; 2022 Aug; 190():110027. PubMed ID: 35917992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.
    Fracanzani AL; Valenti L; Russello M; Miele L; Bertelli C; Bellia A; Masetti C; Cefalo C; Grieco A; Marchesini G; Fargion S
    PLoS One; 2012; 7(7):e41183. PubMed ID: 22848440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between neck circumference and markers of dysglycemia, non-alcoholic fatty liver disease, and dysmetabolism independent of Body Mass Index in an Emirati population.
    Fojas EGF; Buckley AJ; Lessan N
    Front Endocrinol (Lausanne); 2022; 13():929724. PubMed ID: 36147574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and predictors of non-alcoholic fatty liver disease in prediabetes.
    Rajput R; Ahlawat P
    Diabetes Metab Syndr; 2019; 13(5):2957-2960. PubMed ID: 31425963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D; Bril F; Kalavalapalli S; Cusi K
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
    Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
    J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.